|
Volumn 38, Issue 6, 2006, Pages 1696-1698
|
Results of Intestinal and Multivisceral Transplantation in Adult Patients: Italian Experience
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALEMTUZUMAB;
DACLIZUMAB;
IMMUNOSUPPRESSIVE AGENT;
INFUSION FLUID;
RAPAMYCIN;
STEROID;
TACROLIMUS;
THYMOCYTE ANTIBODY;
ABDOMINAL WALL;
ADULT;
ARTICLE;
BACTERIAL INFECTION;
CHRONIC GRAFT REJECTION;
CLINICAL ARTICLE;
DISEASE ASSOCIATION;
ELECTROLYTE DISTURBANCE;
FEMALE;
FOLLOW UP;
GRAFT FAILURE;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE FUNCTION;
INTESTINE GRAFT;
INTESTINE TRANSPLANTATION;
ITALY;
LAPAROTOMY;
LIVER TRANSPLANTATION;
MALE;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RECURRENT DISEASE;
SEPSIS;
SURVIVAL RATE;
TOTAL PARENTERAL NUTRITION;
TREATMENT INDICATION;
VISCERA;
ADULT;
CADAVER;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INTESTINES;
ITALY;
LIVER DISEASES;
PARENTERAL NUTRITION, TOTAL;
RETROSPECTIVE STUDIES;
TACROLIMUS;
TISSUE AND ORGAN HARVESTING;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT FAILURE;
VISCERA;
|
EID: 33746896552
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.05.021 Document Type: Article |
Times cited : (11)
|
References (4)
|